SciELO - Scientific Electronic Library Online

 
vol.12 número2Avances en la genética de los glaucomasResultados de la macrotrabeculectomía en el glaucoma primario de ángulo abierto índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Oftalmología

versión On-line ISSN 1561-3070

Resumen

GARCIA GONZALEZ, Francisco; VIERA ROSALES, Mercy  y  SEDENO CRUZ, Ibis. Mitomycin C in non-penetrating deep sclerostomy. Rev Cubana Oftalmol [online]. 1999, vol.12, n.2, pp. 0-0. ISSN 1561-3070.

We intend in this paper to assess the effectiveness of Mitomycin C as a fibroblastic proliferation inhibitor in the non-penetrating deep sclerostomy (NPDS). This procedure was performed in 40 eyes with primary chronic glaucoma, 20 of them were treated with intraoperative topycal Mitomycin C at 0,5 mg/mL for five minutes and 20 were not applied this drug. They were followed up and assessed one, six and twelve months after the surgery. In the NPDS without mitomycin C group, intraocular pressure was reduced from 27,40 ± 4,76 mmHg to 15,80 ± 2,50 mmHg, but 5 eyes required betablockers compared to a reduction from 27,35 ± 2,91 mmHg to 7,15 ± 1,67 mmHg without betablockers in the NPDS with Mitomycin C group, which presented and extensive, pale, transparent and avascular filtering ampulla and slight complications such as hyphema and dehiscence. The NPDS with mitomycin C was more effective in controlling intraocular pressure and transoperative topycal monodosage of this drug was well tolerated by the patients.

Palabras clave : MITOMYCIN C [therapeutic use]; SCLEROSTOMY.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License